Quarterly financial results and related announcements
日本語
English
Results and Announcements
Fiscal 2023
Fiscal 2022
- 2023.05.12 Summary of Consolidated Financial Results for FY2022 (PDF : 275.5KB)
- 2023.02.03 Summary of Consolidated Financial Results for Third Quarter of FY2022 (PDF : 245.1KB)
- 2022.11.08 Summary of Consolidated Financial Results for Second Quarter of FY2022 (PDF : 334.5KB)
- 2022.08.05 Summary of Consolidated Financial Results for First Quarter of FY2022 (PDF : 581.7KB)
- 2022.08.05 Notice for Revisions of Financial Forecasts (PDF : 75.4KB)
Fiscal 2021
- 2022.05.13 Summary of Consolidated Financial Results for FY2021 (PDF : 979KB)
- 2022.05.13 Notice Regarding the Recording of Impairment Loss and Loss on Valuation of Shares of Subsidiaries and Affiliates (PDF : 39.9KB)
- 2022.02.03 Summary of Consolidated Financial Results for Third Quarter of FY2021 (PDF : 830KB)
- 2022.02.03 Notice for Revisions of Dividend Forecast (PDF : 41.0KB)
- 2021.11.05 Summary of Consolidated Financial Results for Second Quarter of FY2021 (PDF : 536KB)
- 2021.08.05 Summary of Consolidated Financial Results for First Quarter of FY2021 (PDF : 541KB)
- 2021.08.05 Notice for Revisions of Financial Forecasts (PDF : 42KB)
Fiscal 2020
- 2021.05.14 Notice Regarding Commencement of Tender Offer for Shares of Honshu Chemical Industry Co., Ltd. (Securities Code: 4115) (PDF : 457.4KB)
- 2021.05.13 Summary of Consolidated Financial Results for FY2020 (PDF : 857.2KB)
- 2021.02.09 Notice for Revisions of Financial Forecasts (PDF : 40.5KB)
- 2021.02.09 Summary of Consolidated Financial Results for Third Quarter of FY2020 (PDF : 627.3KB)
- 2020.11.11 Summary of Consolidated Financial Results for Second Quarter of FY2020 (PDF : 627.7KB)
- 2020.11.05 Notice for Revisions of Financial Forecasts (PDF : 40.6KB)
- 2020.08.13 Summary of Consolidated Financial Results for First Quarter of FY2020 (PDF : 549.6KB)
- 2020.08.13 Notice for Revisions of Financial Forecasts and Dividend Forecast (PDF : 44.8KB)
- 2020.08.13 Disclosure of Financial Results of Delisted Subsidiary ARRK CORPORATION (PDF : 100.5KB)
Fiscal 2019
-
2020.05.14
Re Execution of Share Exchange Agreement Concerning ARRK Becoming A Wholly-Owned Subsidiary of MCI (PDF : 117.8KB)
【Attachment】 (PDF : 287.4KB) - 2020.05.14 Differences in Actual Non-consolidated Results of ARRK Corporation between Current Fiscal Year and Previous Fiscal Year (PDF : 38.8KB)
- 2020.05.14 Notice Re Enhancement of the Business and Capital Tie-up between Shofu, MCI, and Sun Medical (PDF : 877.9KB)
- 2020.05.14 Summary of Consolidated Financial Results for FY2019 (PDF : 877.9KB)
- 2020.05.08 Notice Regarding the Recording of Extraordinary Loss, Setting of Allowance for Doubtful Accounts, and Revisions of Financial Forecasts for FY2019 (PDF : 42.1KB)
- 2020.03.27 Notice Regarding Establishment of Employees’ Retirement Benefit Trust and the Recording of Extraordinary Income (PDF : 100.6KB)
- 2020.02.05 Summary of Consolidated Financial Results for Third Quarter of FY2019 (PDF : 610.3KB)
- 2020.02.05 Notice Regarding Establishment of Employees' Retirement Benefit Trust, the Recording of Extraordinary Income, and Revisions of Financial Forecasts for FY2019 (PDF : 117.6KB)
- 2019.11.06 Notice on Voluntary Adoption of International Financial Reporting Standards (IFRS) (PDF : 43.5KB)
- 2019.11.06 Differences between Financial Forecasts and Actual Results for the First Half, and Revisions of Financial Forecasts for FY2019 (PDF : 46.1KB)
- 2019.11.06 Summary of Consolidated Financial Results for Second Quarter of FY2019 (PDF : 196.7KB)
- 2019.08.01 Summary of Consolidated Financial Results for First Quarter of FY2019 (PDF : 190.8KB)